MX2022015836A - Composiciones y metodos para el cuidado ocular posoperatorio. - Google Patents

Composiciones y metodos para el cuidado ocular posoperatorio.

Info

Publication number
MX2022015836A
MX2022015836A MX2022015836A MX2022015836A MX2022015836A MX 2022015836 A MX2022015836 A MX 2022015836A MX 2022015836 A MX2022015836 A MX 2022015836A MX 2022015836 A MX2022015836 A MX 2022015836A MX 2022015836 A MX2022015836 A MX 2022015836A
Authority
MX
Mexico
Prior art keywords
post
compositions
operative ocular
ocular care
care
Prior art date
Application number
MX2022015836A
Other languages
English (en)
Inventor
Anthony Sampietro
Damien Goldberg
Amy Frost
Brian Holdorf
Francis Mah
Original Assignee
Ocular Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ocular Science Inc filed Critical Ocular Science Inc
Publication of MX2022015836A publication Critical patent/MX2022015836A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

En este documento se proporcionan ciertas formulaciones oftálmicas sin conservantes para el cuidado ocular posoperatorio.
MX2022015836A 2020-06-10 2021-04-05 Composiciones y metodos para el cuidado ocular posoperatorio. MX2022015836A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063037171P 2020-06-10 2020-06-10
PCT/US2021/025754 WO2021252054A1 (en) 2020-06-10 2021-04-05 Compositions and uses in method for post-operative ocular care

Publications (1)

Publication Number Publication Date
MX2022015836A true MX2022015836A (es) 2023-03-28

Family

ID=75660389

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022015836A MX2022015836A (es) 2020-06-10 2021-04-05 Composiciones y metodos para el cuidado ocular posoperatorio.

Country Status (8)

Country Link
US (2) US20210386759A1 (es)
EP (1) EP4164625A1 (es)
JP (1) JP2023530254A (es)
AU (1) AU2021289250A1 (es)
CA (1) CA3182196A1 (es)
GB (1) GB2613469A (es)
MX (1) MX2022015836A (es)
WO (1) WO2021252054A1 (es)

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5052558A (en) 1987-12-23 1991-10-01 Entravision, Inc. Packaged pharmaceutical product
US5033252A (en) 1987-12-23 1991-07-23 Entravision, Inc. Method of packaging and sterilizing a pharmaceutical product
US5505953A (en) 1992-05-06 1996-04-09 Alcon Laboratories, Inc. Use of borate-polyol complexes in ophthalmic compositions
US5323907A (en) 1992-06-23 1994-06-28 Multi-Comp, Inc. Child resistant package assembly for dispensing pharmaceutical medications
AR020661A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
FR2952040B1 (fr) 2009-10-29 2011-12-30 Rexam Pharma La Verpilliere Dispositif de distribution de liquide sous forme de gouttes
EP2593056B1 (en) 2010-07-15 2020-10-21 Eyenovia, Inc. Drop generating device
US10154923B2 (en) * 2010-07-15 2018-12-18 Eyenovia, Inc. Drop generating device
EA201390120A3 (ru) 2010-07-15 2013-09-30 Коринтиан Офтэлмик, Инк. Доставка офтальмологических лекарственных средств
SG11201407428YA (en) 2012-05-14 2014-12-30 Eyenovia Inc Laminar flow droplet generator device and methods of use
KR102234042B1 (ko) 2012-05-15 2021-03-30 아이노비아 인코포레이티드 이젝터 디바이스들, 방법들, 드라이버들, 및 그를 위한 회로들
US20160243031A1 (en) * 2013-07-22 2016-08-25 Imprimis Pharmaceuticals, Inc. Pharmaceutical ophthalmic compositions and methods for fabricating thereof
DE102013218802B4 (de) 2013-09-19 2018-06-28 Aero Pump Gmbh Abgabevorrichtung für Fluide aus einem Fluidbehälter
DE102015104646B3 (de) 2015-03-26 2016-06-30 Aero Pump Gmbh Abgabevorrichtung für ein Fluid
JP6694525B2 (ja) * 2016-05-06 2020-05-13 ハーロウ・ヘルス・インコーポレイテッドＨａｒｒｏｗ Ｈｅａｌｔｈ， Ｉｎｃ． 薬学的眼病用組成物およびそれを製造するための方法
US20180318319A1 (en) * 2017-05-04 2018-11-08 Ocular Science, Inc. Compositions and Methods for Treating Eyes and Methods of Preparation
TW202005623A (zh) * 2018-04-06 2020-02-01 美商蒂克利爾公司 用於輸送治療劑之系統及方法

Also Published As

Publication number Publication date
US20210386759A1 (en) 2021-12-16
WO2021252054A1 (en) 2021-12-16
AU2021289250A1 (en) 2023-02-16
US20230066798A1 (en) 2023-03-02
CA3182196A1 (en) 2021-12-16
EP4164625A1 (en) 2023-04-19
JP2023530254A (ja) 2023-07-14
GB202300019D0 (en) 2023-02-15
GB2613469A (en) 2023-06-07

Similar Documents

Publication Publication Date Title
MX2011013060A (es) Formulaciones oftalmicas, metodos de preparacion y metodos para utilizarlas.
MX368377B (es) Combinacion de brimonidina y timolol para uso oftalmico, topico.
MX2009012645A (es) Formulaciones y metodos para tratar el ojo seco.
MX2023003124A (es) Composiciones farmaceuticas oftalmicas y usos que se relacionan a las mismas.
MX370963B (es) Composiciones para el cuidado personal.
EA202191559A1 (ru) Модифицированные аминовые липиды
CL2013003016A1 (es) Una composicion oftalmica topica para el tratamiento y/o la profilaxis de una infeccion producida por un microorganismo o un trastorno de al menos un tejido ocular, que comprende a) 0,01 a 10% de povidona yodada y b) un esteroide seleccionado de acetato de prednisolona, etabonato de loteprednol, difluprednato, entre otros, o bromfenaco.
MX2018014868A (es) Composiciones y metodos de uso de nintedanib para mejorar el exito de la cirugia del glaucoma.
PH12020551766A1 (en) Use of pilocarpine hydrochloride for the treatment of ocular conditions
EP3653205A3 (en) Oxymethazoline for topical ophthalmic administration and uses thereof
NZ755442A (en) Topical cyclosporine-containing formulations and uses thereof
WO2019099921A3 (en) Vegfr-fc fusion protein formulations
MX2016015211A (es) Formulaciones topicas y usos de las mismas.
PH12021550621A1 (en) Ophthalmic compositions for treatment of ocular surface damage and symptoms of dryness
WO2021236957A3 (en) Ace2 muteins and methods of using the same
MX2022012692A (es) Composiciones que comprenden nanoparticulas, metodo de elaboracion y usos de las mismas.
NZ766141A (en) Isoxazoline parasiticide formulations and methods for treating blepharitis
MX2020003534A (es) Composiciones oftalmicas que comprenden latanoprost para usarse en el tratamiento de las enfermedades oculares.
MY178169A (en) Topical ophthalmic peptide formulation
AR058141A1 (es) Composiciones topicas de n,2,3 -trimetil-2- isopropilbutamida para el alivio del dolor y metodos para usarlas
CO6592061A2 (es) Combinación triple para reducir la presión intraocular
MX2022015836A (es) Composiciones y metodos para el cuidado ocular posoperatorio.
MX2021014000A (es) Formulaciones oftalmicas topicas de liposomas cargados con acetonido de triamcinolona para la prevencion del engrosamiento macular y sus resultados visuales asociados despues de la cirugia del cristalino.
MX2023009921A (es) Formulaciones de proteinas de fusion ace2-fc.
MX2021015781A (es) Formulacion de base lipidica de uso topico oftalmico, que contiene extracto de arandano azul como componente principal para hacer mas eficiente la penetracion y biodisponibilidad de sus bioactivos en tejidos blancos intraoculares en seres humanos.